Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NA-831 in Alzheimer's MCI
NCT03538522Phase 2Completed
- Sponsor
- Biomed Industries
- Start
- Sep 2018
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclo(prolylglycyl) in Alzheimer's disease (AD), sponsored by Biomed Industries. Started Sep 2018; status: completed.
02
Drugs
cyclo(prolylglycyl)
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03538522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03538522.